DrugDashboards

Triamcinolone Acetonide

Triamcinolone Acetonide · TRIAMCINOLONE ACETONIDE 40 mg/mL · Injection, Suspension · Intra-Articular; Intramuscular · Dr. Reddy's Laboratories Inc

NDC 43598-0677-11 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 1 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

22 companies supply this market — deep enough that no single failure threatens the supply. A shortage here was resolved within the past year — markets usually stay tight for a while after. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 4× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for triamcinolone acetonide (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $10.46 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA218421
TE code
AB
Approval date
Apr 11, 2025
Patents / exclusivity
None on file

Shortage history

  • Shortage ended — Triesence, Injection, 40 mg/1 mL (NDC 82667-800-01)Sep 27, 2021 → Jul 31, 2026

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Triamcinolone Acetonide (Injection, Suspension)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 3, 2026
Amneal Pharmaceuticals LLCTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 3, 2026
Eugia US LLCTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 3, 2026
Teva Parenteral Medicines, Inc.TRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsTRIAMCINOLONE ACETONIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Advanced Rx Pharmacy of Tennessee, LLCTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.TRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.TRIAMCINOLONE ACETONIDE 200 mg/5mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.TRIAMCINOLONE ACETONIDE 400 mg/10mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedTRIAMCINOLONE ACETONIDE 200 mg/5mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedTRIAMCINOLONE ACETONIDE 400 mg/10mLJul 15, 2026Sep 2, 2026
Asclemed Usa Inc.TRIAMCINOLONE ACETONIDE 200 mg/5mLJul 15, 2026Sep 2, 2026
Asclemed Usa Inc.TRIAMCINOLONE ACETONIDE 400 mg/10mLJul 15, 2026Sep 2, 2026
Bausch & Lomb IncorporatedTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories IncTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories IncTRIAMCINOLONE ACETONIDE 400 mg/10mLJul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories IncTRIAMCINOLONE ACETONIDE 200 mg/5mLJul 15, 2026Sep 2, 2026
Dr. Reddy's Labortories IncTRIAMCINOLONE ACETONIDE 10 mg/mLJul 15, 2026Sep 2, 2026
E.R. Squibb & Sons, L.L.C.TRIAMCINOLONE ACETONIDE 10 mg/mLJul 15, 2026Sep 2, 2026
E.R. Squibb & Sons, L.L.C.TRIAMCINOLONE ACETONIDE 80 mg/mLJul 15, 2026Sep 2, 2026
E.R. Squibb & Sons, L.L.C.TRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Harrow Eye, LLCTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.TRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCTRIAMCINOLONE ACETONIDE 400 mg/10mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCTRIAMCINOLONE ACETONIDE 200 mg/5mLJul 15, 2026Sep 2, 2026
NorthStar Rx LLCTRIAMCINOLONE ACETONIDE 200 mg/5mLJul 15, 2026Sep 2, 2026
NorthStar Rx LLCTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
NorthStar Rx LLCTRIAMCINOLONE ACETONIDE 400 mg/10mLJul 15, 2026Sep 2, 2026
Novartis Pharmaceuticals CorporationTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Proficient Rx LPTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.TRIAMCINOLONE ACETONIDE 400 mg/10mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsTRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCTRIAMCINOLONE ACETONIDE 200 mg/5mLJul 15, 2026Aug 31, 2026
Asclemed USA, Inc.TRIAMCINOLONE ACETONIDE 40 mg/mLJul 15, 2026Aug 31, 2026
Sportpharm LLCTRIAMCINOLONE ACETONIDE 400 mg/10mLJul 15, 2026Aug 31, 2026
Amneal Pharmaceuticals LLCTRIAMCINOLONE ACETONIDE 400 mg/10mLJul 15, 2026Aug 28, 2026
Sportpharm LLCTRIAMCINOLONE ACETONIDE 200 mg/5mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Triamcinolone Acetonide — NDC 43598-0677-11," retrieved September 3, 2026, https://drugdashboards.com/drug/43598067711.

Free to cite with attribution — see how the data is put together.